PD-Rx Pharmaceuticals (OTCPK:PDRX) - Stock Price, News & Analysis

PDRX Stock Overview

Engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. More details

PDRX fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Rewards

Trading at 45.8% below our estimate of its fair value

Risk Analysis

Does not have a meaningful market cap ($6M)

Revenue has declined by 25.9% over the past year

Shares are highly illiquid

Latest financial reports are more than 6 months old

PD-Rx Pharmaceuticals, Inc. Competitors

Fuse Medical

OTCPK:FZMD

US$5.8m

Agape ATP

NasdaqCM:ATPC

US$6.2m

Cosmos Health

NasdaqCM:COSM

US$16.2m

Kun Peng International

OTCPK:KPEA

US$37.5m

Price History & Performance

Summary of all time highs, changes and price drops for PD-Rx Pharmaceuticals
Historical stock prices
Current Share Price	US$3.61
52 Week High	US$7.50
52 Week Low	US$0.000001
Beta	1129406.61
11 Month Change	-1.10%
3 Month Change	n/a
1 Year Change	-48.43%
33 Year Change	44.40%
5 Year Change	-19.78%
Change since IPO	140.67%

Recent updates

Shareholder Returns

	PDRX	US Healthcare	US Market
7D	0%	2.0%	1.6%
1Y	-48.4%	7.5%	32.3%

Return vs Industry: PDRX underperformed the US Healthcare industry which returned 4.6% over the past year.

Return vs Market: PDRX underperformed the US Market which returned 32.4% over the past year.

Price Volatility

Is PDRX's price volatile compared to industry and market?
PDRX volatility
PDRX Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.0%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.2%
10% least volatile stocks in US Market	3.1%

Stable Share Price: PDRX's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PDRX's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1986	n/a	Robert Holsey	www.pdrx.com

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspensions products; and packaging services. It also provides dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as handling package; and PD-Rx Net, a web-based application designed to track prescriptions filled at the point of care and print prescription labels for prescription that are filled onsite.

PD-Rx Pharmaceuticals, Inc. Fundamentals Summary

How do PD-Rx Pharmaceuticals's earnings and revenue compare to its market cap?
PDRX fundamental statistics
Market cap	US$5.94m
Earnings (TTM)	-US$98.06k
Revenue (TTM)	US$21.27m

0.3x

P/S Ratio

-60.5x

P/E Ratio

Is PDRX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PDRX income statement (TTM)
Revenue	US$21.27m
Cost of Revenue	US$14.56m
Gross Profit	US$6.71m
Other Expenses	US$6.81m
Earnings	-US$98.06k

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.06
Gross Margin	31.56%
Net Profit Margin	-0.46%
Debt/Equity Ratio	0%

How did PDRX perform over the long term?

See historical performance and comparison

PD-Rx Pharmaceuticals OTCPK:PDRX Stock Report